300 related articles for article (PubMed ID: 15120041)
1. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages.
Bibby MC
Eur J Cancer; 2004 Apr; 40(6):852-7. PubMed ID: 15120041
[TBL] [Abstract][Full Text] [Related]
2. Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development.
Peterson JK; Houghton PJ
Eur J Cancer; 2004 Apr; 40(6):837-44. PubMed ID: 15120039
[TBL] [Abstract][Full Text] [Related]
3. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
5. [Preclinical evaluation of anticancer drugs: a model remaining a model!].
Lavelle F
Bull Cancer; 1998 Oct; 85(10):837-42. PubMed ID: 9835860
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
Hansen K; Khanna C
Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
[TBL] [Abstract][Full Text] [Related]
7. The hollow fibre model in cancer drug screening: the NCI experience.
Decker S; Hollingshead M; Bonomi CA; Carter JP; Sausville EA
Eur J Cancer; 2004 Apr; 40(6):821-6. PubMed ID: 15120037
[TBL] [Abstract][Full Text] [Related]
8. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
9. Development of chondrosarcoma animal models for assessment of adjuvant therapy.
Clark JC; Dass CR; Choong PF
ANZ J Surg; 2009 May; 79(5):327-36. PubMed ID: 19566512
[TBL] [Abstract][Full Text] [Related]
10. Mouse orthotopic models for bladder cancer research.
Chan E; Patel A; Heston W; Larchian W
BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
[TBL] [Abstract][Full Text] [Related]
11. Human tumour xenografts.
Double JA
Biomedicine; 1975 Nov; 22(6):461-5. PubMed ID: 773441
[TBL] [Abstract][Full Text] [Related]
12. The mighty mouse: genetically engineered mouse models in cancer drug development.
Sharpless NE; Depinho RA
Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?
Damia G; D'Incalci M
Eur J Cancer; 2009 Nov; 45(16):2768-81. PubMed ID: 19762228
[TBL] [Abstract][Full Text] [Related]
15. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.
Suggitt M; Bibby MC
Clin Cancer Res; 2005 Feb; 11(3):971-81. PubMed ID: 15709162
[TBL] [Abstract][Full Text] [Related]
16. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
Prestwich GD
Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
[TBL] [Abstract][Full Text] [Related]
17. The use of animal models in cancer drug discovery and development.
Curt GA
Stem Cells; 1994 Jan; 12(1):23-9. PubMed ID: 8142918
[TBL] [Abstract][Full Text] [Related]
18. [Pretherapeutic detection of tumour resistance to cytostatic agents].
Volm M; Mattern J
Wien Klin Wochenschr; 1982 Nov; 94(22):599-604. PubMed ID: 7164463
[TBL] [Abstract][Full Text] [Related]
19. The development of molecularly targeted anticancer therapies: an Eli Lilly and Company perspective.
Perry WL; Weitzman A
Clin Adv Hematol Oncol; 2005 Mar; 3(3):199-202, 237-8. PubMed ID: 16166991
[TBL] [Abstract][Full Text] [Related]
20. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
